Imaging Mass Spectrometry Reveals Tumor Metabolic Heterogeneity

Malignant tumors exhibit high degrees of genomic heterogeneity at the cellular level, leading to the view that subpopulations of tumor cells drive growth and treatment resistance. To examine the degree to which tumors also exhibit metabolic heterogeneity at the level of individual cells, we employed...

Full description

Saved in:
Bibliographic Details
Published iniScience Vol. 23; no. 8; p. 101355
Main Authors Zhang, Yang, Guillermier, Christelle, De Raedt, Thomas, Cox, Andrew G., Maertens, Ophelia, Yimlamai, Dean, Lun, Mingyue, Whitney, Adam, Maas, Richard L., Goessling, Wolfram, Cichowski, Karen, Steinhauser, Matthew L.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 21.08.2020
Elsevier
Subjects
Biological Sciences
Cancer Systems Biology
Biological Sciences
Cancer Systems Biology
Online AccessGet full text

Cover

More Information
Summary:Malignant tumors exhibit high degrees of genomic heterogeneity at the cellular level, leading to the view that subpopulations of tumor cells drive growth and treatment resistance. To examine the degree to which tumors also exhibit metabolic heterogeneity at the level of individual cells, we employed multi-isotope imaging mass spectrometry (MIMS) to quantify utilization of stable isotopes of glucose and glutamine along with a label for cell division. Mouse models of melanoma and malignant peripheral nerve sheath tumors (MPNSTs) exhibited striking heterogeneity of substrate utilization, evident in both proliferating and non-proliferating cells. We identified a correlation between metabolic heterogeneity, proliferation, and therapeutic resistance. Heterogeneity in metabolic substrate usage as revealed by incorporation of glucose and glutamine tracers is thus a marker for tumor proliferation. Collectively, our data demonstrate that MIMS provides a powerful tool with which to dissect metabolic functions of individual cells within the native tumor environment. [Display omitted] •A method to measure substrate utilization at single cancer cell resolution•Heterogeneity of glucose and glutamine utilization in murine tumors•Metabolic heterogeneity in proliferating and non-proliferating tumor cells•Metabolic heterogeneity correlates with proliferative growth and treatment resistance Biological Sciences; Cancer Systems Biology
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Lead Contact
ISSN:2589-0042
2589-0042
DOI:10.1016/j.isci.2020.101355